Mobile

A Phase III, Randomised, Double-blind Study to Assess the Efficacy and Safety of 10 mg ZD4054 versus Placebo in Patients with Hormone-resistant Prostate Cancer and Bone Metastasis who are Pain Free or...

Mise à jour : Il y a 5 ans
Référence : EUCTR2007-003227-20

A Phase III, Randomised, Double-blind Study to Assess the Efficacy and Safety of 10 mg ZD4054 versus Placebo in Patients with Hormone-resistant Prostate Cancer and Bone Metastasis who are Pain Free or Mildly Symptomatic

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

To determine the effect of ZD4054 on overall survival, defined as time to death (from randomisation) from any cause, compared to placebo

Critère d'inclusion

  • hormone-resistant prostate cancer

Liens